Physical Therapists in Lakeland, TN Accepting Medicare

7 Physical Therapists found. Showing 1 - 7

Faith Mccormack, P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 9754 Pine Point Dr, Lakeland, TN 38002 Phone: 901-382-5052    Fax: 901-382-5052

Abigail Lynn Schroeppel, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 3085 Champions Dr, Apt. 204, Lakeland, TN 38002 Phone: 901-212-3565

Lynn A. Saino, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 9160 Highway 64, Suite 3, Lakeland, TN 38002 Phone: 901-388-4474    Fax: 901-388-4486

Leader Physical Therapy Limited Partnership Physical Therapist Medicare: Medicare Enrolled Practice Location: 2961 Canada Rd Ste 107, Lakeland, TN 38002 Phone: 901-866-9239    Fax: 901-654-3288

Rehab & Pain Therapy Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 9160 Highway 64 Ste 3, Lakeland, TN 38002 Phone: 901-388-4474    Fax: 901-388-4486

Mrs. Resa Saturday Barawid, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 9160 Highway 64, Suite 3, Lakeland, TN 38002 Phone: 901-388-4474    Fax: 901-388-4486

Mr. Diosdado A Barawid Jr., PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 9160 Highway 64 Ste 3, Lakeland, TN 38002 Phone: 901-388-4474    Fax: 901-388-4486

News Archive

Single-cell transcriptomic analysis uncovers subgroups of colorectal tumors

Combining single-cell genomics and computational techniques, a research team including Paul Robson, Ph.D., director of single-cell biology at The Jackson Laboratory, has defined cell-type composition of cancerous cells from 11 colorectal tumors, as well as adjacent noncancerous cells, a key to more targeted diagnosis and treatment.

AJCC Cancer Staging Manual brings together the relevant, evidence-based criteria for staging of cancer

Physicians and health care professionals around the world need a tool to facilitate the uniform description and reporting of cancer. Proper staging is essential to determine appropriate treatment, evaluate results of management and clinical trials, and to serve as the standard for local, regional and international reporting on cancer incidence and outcomes.

Aileron Therapeutics concludes first-in-human study of ALRN-5281 Stapled Peptide drug

Aileron Therapeutics, Inc. today announced the completion of the first-in-human study of its lead Stapled Peptide drug, ALRN-5281, a proprietary, long-acting growth-hormone-releasing hormone (GHRH) agonist for treating orphan endocrine disorders, including adult growth hormone (GH) deficiency and human immunodeficiency virus (HIV) lipodystrophy, as well as broader patient populations involving a wide variety of metabolic/endocrine diseases.

Penn, UGA scientists awarded new contract to develop genome database for microbial pathogens

At the turn of the millennium, the cost to sequence a single human genome exceeded $50 million, and the process took a decade to complete. Microbes have genomes, too, and the first reference genome for a malaria parasite was completed in 2002 at a cost of roughly $15 million. But today researchers can sequence a genome in a single afternoon for just a few thousand dollars. Related technologies make it possible to capture information about all genes in the genome, in all tissues, from multiple individuals.

Low dose aspirin dosages trigger the body to generate its own anti-inflammatory compounds

Researchers at Brigham and Women's Hospital (BWH) and colleagues have demonstrated for the first time in humans in a randomized clinical trial that low-dose aspirin - dosages equivalent to one baby aspirin (81 mg) - trigger the body to generate its own anti-inflammatory compounds that help fight unwanted inflammation.

Read more Medical News

› Verified 5 days ago